Attenuation of the anorectic effects of glucagon, cholecystokinin, and bombesin by the amylin receptor antagonist CGRP(8-37)

Peptides

Volumn 17, Issue 1, 1996, Pages 119-124

  Lutz, T A ^a   Del Prete, E ^a   Szabady, M M ^a   Scharrer, E ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Amylin; Bombesin; CGRP(8 37); Cholecystokinin; Food intake; Glucagon; IP injection; Rat; Vasopressin

Indexed keywords

AMYLIN; AMYLIN RECEPTOR ANTAGONIST; BOMBESIN; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE[8-37]; CHOLECYSTOKININ; GLUCAGON; UNCLASSIFIED DRUG; VASOPRESSIN;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; FOOD INTAKE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030028864     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0196-9781(95)02046-2     Document Type: Article

References (58)

1. Balasubramaniam, A.; Renugopalakrishan, V.; Stein, M.; Fischer, J. E.; Chance, W. T. Synthesis, structures and anorectic effects of human and rat amylin. Peptides 12:919-924; 1991.
2. Banks, W. A.; Kastin, A. J. Peptide transport systems for opiates across the blood-brain barrier. Am. J. Physiol. 259:E1-E10; 1990.
3. Baura, G. D.; Foster, D. M.; Porte, D., Jr.; et al. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. J. Clin. Invest. 92:1824-1830; 1993.
4. Beaumont, K.; Kenney, M. A.; Young, A. A.; Rink, T. J. High affinity amylin binding sites in rat brain. Molecul. Pharmacol. 44:493-497; 1993.
5. Bellinger, L. L.; Williams, F. E. Glucagon and epinephrine suppression of food intake in liver-denervated rats. Am. J. Physiol. 251:R349-R358; 1986.
6. Bhogal, R.; Smith, D. M.; Bloom, S. R. Investigation and characterization of binding sites for islet amyloid polypeptide in rat membranes. Endocrinology 130:906-913; 1992.
7. Butler, P. C.; Chou, J.; Carter, W. B.; et al. Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 39:752-756; 1990.
8. Chance, W. T.; Balasubramaniam, A.; Zhang, F. S.; Wimalawansa, S. J.; Fischer, J. E. Anorexia following the intrahypothalamic administration of amylin. Brain Res. 539:352-354; 1991.
9. Chance, W. T.; Balasubramaniam, A.; Chen, X.; Fischer, J. E. Tests of adipsia and conditioned taste aversion following the intrahypothalamic injection of amylin. Peptides 13:961-964; 1992.
10. Cooper, G. J. S. Amylin compared with calcitonin gene-related peptide: Structure, biology and relevance to metabolic disease. Endocr. Rev. 15:163-201; 1994.
11. 14C-glycogen accumulation. Biochem. Biophys. Res. Commun. 181:116-120; 1991.
12. Gao, Z.-Y.; Drews, G.; Nenquin, M.; Plant, T. D.; Henquin, J.-C. Mechanisms of the stimulation of insulin release by arginine-vasopressin in normal mouse islets. J. Biol. Chem. 265:15724-15730; 1990.
13. Geary, N.; Langhans, W.; Scharrer, E. Metabolic concomitants of glucagon-induced suppression of feeding in the rat. Am. J. Physiol. 241:R330-R335; 1981.
14. Geary, N.; Smith, G. P. Selective hepatic vagotomy blocks pancreatic glucagon's satiety effect. Physiol. Behav. 31:391-394; 1983.
15. Hems, D. A.; Whitton, P. D.; Ma, G. Y. Metabolic actions of vasopressin, glucagon and adrenalin in the intact rat. Biochim. Biophys. Acta 411:155-164; 1975.
16. Holzer, P. Calcitonin gene-related peptide. In: Walsh, J. H.; Dockray, G. J., eds. Gut peptides: Biochemistry and physiology. New York: Raven Press; 1994:493-523.
17. Inoue, K.; Hisatomi, A.; Umeda, F.; Nawata, H. Effects of glucagon-like peptide 1 (7-36) amide and glucagon on amylin release from perfused rat pancreas. Horm. Metab. Res. 23:407-409; 1991.
18. Inoue, K.; Hiramatsu, S.; Hisatomi, A.; Umeda, F.; Nawata, H. Effects of amylin on the release of insulin and glucagon from the perfused rat pancreas. Horm. Metab. Res. 25:135-137; 1993.
19. Ipp, E.; Unger, R. H. Bombesin stimulates the release of insulin and glucagon, but not pancreatic somatostatin, from the isolated perfused dog pancreas. Endocr. Res. Commun. 6:37-42; 1979.
20. Joyner, K.; Smith, G. P.; Gibbs, J. Abdominal vagotomy decreases the satiating potency of CCK-8 in sham and real feeding. Am. J. Physiol. 264:R912-R916; 1993.
21. Langhans, W.; Zieger, U.; Scharrer, E.; Geary, N. Stimulation of feeding in rats by intraperitoneal injection of antibodies to glucagon. Science 218:894-896; 1982.
22. Langhans, W.; Pantel, K.; Müller-Schell, W.; Eggenberger, E.; Scharrer, E. Hepatic handling of pancreatic glucagon and glucose during meals in rats. Am. J. Physiol. 247:R827-R832; 1984.
23. Langhans, W.; Scharrer, E.; Geary, N. Pancreatic glucagon's effects on satiety and hepatic glucose production are independently affected by diet composition. Physiol. Behav. 36:483-487; 1986.
24. Langhans, W.; Duss, M.; Scharrer, E. Decreased feeding and supra-physiological plasma levels of glucagon after glucagon injection in rats. Physiol. Behav. 41:31-35; 1987.
25. Langhans, W. The antidiuretic hormone: New aspects of an "old" peptide. J. Vet. Med. [A] 35:641-654; 1988.
26. Langhans, W.; Del Prete, E.; Scharrer, E. Mechanisms of vasopressin's anorectic effect. Physiol. Behav. 49:169-176; 1991.
27. Le Sauter, J.; Noh, U.; Geary, N. Hepatic portal infusion of glucagon antibodies increases spontaneous meal size in rats. Am. J. Physiol. 261:R162-R165; 1991.
28. Le Sauter, J.; Geary, N. Le glucagon pancréatique: Signal physiologique de la satiété post prandiale. Ann. Endocrinol. (Paris) 54:149-161; 1993.
29. Liddle, R. A. Cholecystokinin. In: Walsh, J. H.; Dockray, G. J., eds. Gut peptides: Biochemistry and physiology. New York: Raven Press; 1994:175-216.
30. Lu, M.; Soltoff, S. P.; Yaney, G. C.; Boyd, A. E., III. The mechanisms underlying the glucose dependence of arginine vasopressin-induced insulin secretion in beta-cells. Endocrinology 132:2141-2148; 1993.
31. Lutz, T. A.; Del Prete, E.; Scharrer, E. Reduction of food intake in rats by intraperitoneal injection of low doses of amylin. Physiol. Behav. 55:891-895; 1994.
32. Lutz, T. A.; Del Prete, E.; Scharrer, E. Subdiaphragmatic vagotomy does not influence the anorectic effect of amylin. Peptides 16:457-462; 1995.
33. Lutz, T. A.; Del Prete, E.; Szabady, M. M.; Scharrer, E. Circadian anorectic effects of peripherally administered amylin in rats. Z. Ernährungswiss. (Eur. J. Nutr.) 34:214-219; 1995.
34. Lutz, T. A.; Geary, N.; Szabady, M. M.; Del Prete, E.; Scharrer, E. Amylin decreases meal size in rats. Physiol. Behav. (in press).
35. Martindale, R.; Levin, S.; Alfin-Slater, R. Effects of caerulein and bombesin on insulin and glucagon secretion from the isolated, perfused rat pancreas. Regul. Pept. 3:313-324; 1982.
36. McCoy, J. G.; Avery, D. D. Bombesin: Potential integrative peptide for feeding and satiety. Peptides 11:595-607; 1990.
37. Meyer, A. H.; Langhans, W.; Scharrer, E. Vasopressin reduces food intake in goats. Q. J. Exp. Physiol. 74:465-473; 1989.
38. Meyer, A. H.; Langhans, W.; Scharrer, E. Vasopressin affects carbohydrate and fat metabolism in pygmy goats. J. Anim. Physiol. Anim. Nutr. 63:46-52; 1990.
39. Moore, C. X.; Cooper, G. J. S. Co-secretion of amylin and insulin from cultured islet beta-cells: modulation by nutrient secretagogues, islet hormones and hypoglycemic agents. Biochem. Biophys. Res. Commun. 179:1-9; 1991.
40. Morley, J. E.; Flood, J. F. Amylin decreases food intake in mice. Peptides 12:865-869; 1991.
41. Morley, J. E.; Morley, P. M. K.; Flood, J. F. Anorectic effects of amylin in rats over the life span. Pharmacol. Biochem. Behav. 44:577-580; 1993.
42. Morley, J. E.; Flood, J. F.; Horowitz, M.; Morley, P. M. K.; Walter, M. J. Modulation of food intake by peripherally administered amylin. Am. J. Physiol. 267:R178-R184; 1994.
43. Reidelberger, R. D.; O'Rourke, M. F. Potent cholecystokinin antagonist L364718 stimulates food intake in rats. Am. J. Physiol. 257:R1512-R1518; 1989.
44. Ritter, S.; Weatherford, S. C.; Stone, S. L. Glucagon-induced inhibition of feeding is impaired by hepatic portal alloxan injection. Am. J. Physiol. 250:R682-R690; 1986.
45. 1-adrenergic receptors. Pharmacol. Biochem. Behav. 49:897-900; 1994.
46. Schwartz, M. W.; Sipols, A.; Kahn, S. E.; et al. Kinetics and specificity of insulin uptake from plasma into cerebrospinal fluid. Am. J. Physiol. 259:E378-E383; 1990.
47. Silver, A. J.; Morley, J. E. Role of CCK in regulation of food intake. Prog. Neurobiol. 36:23-34; 1991.
48. Silvestre, R. A.; Salas, M.; Degano, P.; Peiro, E.; Marco, J. Reversal of the inhibitory effects of calcitonin gene-related peptide (CGRP) and amylin on insulin secretion by the 8-37 fragment of human CGRP. Biochem. Pharmacol. 45:2343-2347; 1993.
49. 6]bombesin(6-13)methyl ester, but not BW2258U89, increases food intake in rats. Pharmacol. Biochem. Behav. 50:463-471; 1995.
50. Stridsberg, M.; Eriksson, B.; Lundqvist, G.; Skogseid, B.; Wilander, E.; Öberg, K. Islet amyloid polypeptide (IAPP) in patients with neuroendocrine tumours. Regul. Pept. 55:119-131; 1995.
51. Triscari, J.; Sullivan, A. C. Comparative effects of vasopressin on lipid and carbohydrate metabolism in lean and obese Zucker rats. Nutr. Rep. Int. 24:305-311; 1981.
52. Wang, M. W.; Young, A. A.; Rink, T. J.; Cooper, G. J. S. 8-37-h-CGRP antagonizes actions of amylin on carbohydrate metabolism in vitro and in vivo. FEBS Lett. 291:195-198; 1991.
53. Wang, Z.-L.; Bennet, W. M.; Ghatei, M. A.; Byfield, P. G. H.; Smith, D. M.; Bloom, S. R. Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets. Diabetes 42:330-335; 1993.
54. Weatherford, S. C.; Ritter, S. Glucagon satiety: Diurnal variation after hepatic branch vagotomy or intraportal alloxan. Brain Res. Bull. 17:545-549; 1986.
55. Weatherford, S. C.; Ritter, S. Lesion of vagal afferent terminals impairs glucagon-induced suppression of food intake. Physiol. Behav. 43:645-650; 1988.
56. Woods, S. C.; Stein, L. J.; Figlewicz, D. P.; Porte, D., Jr. Bombesin stimulates insulin secretion and reduces food intake in the baboon. Peptides 4:687-691; 1983.
57. Young, A. A.; Carlo, P.; Rink, T. J.; Wang, M.-W. 8-37-Human CGRP, an amylin receptor antagonist, enhances the insulin response and perturbs the glucose response to infused arginine in anesthetized rats. Mol. Cell. Endocrinol. 84:R1-R5: 1992.
58. Young, A. A.; Gedulin, B.; Gaeta, L. S. L.; et al. Selective amylin antagonist suppresses rise in plasma lactate after intravenous glucose in the rat - evidence for a metabolic role of endogenous amylin. FEBS Lett. 343:237-241; 1994.